GLP-1 Medications Gaining Popularity for New Year's Weight Loss Resolutions

Health News

GLP-1 Medications Gaining Popularity for New Year's Weight Loss Resolutions
GLP-1Weight LossNew Year's Resolutions
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 27 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 71%

A new survey reveals that almost three-quarters of UK women are considering GLP-1 medications for weight loss in 2025. Previous attempts at dieting and exercise have often proven challenging, leading many to seek new solutions. While access and stigma remain concerns, the increasing interest in GLP-1s emphasizes the need for comprehensive support and care.

JuniperJan 3 2025 As 2024 draws to a close, the new year ushers in the opportunity to set new goals for the year ahead. While weight-loss and fitness are staples of New Year resolutions they are commonly known to be the unsustainable resolutions that don't continue past January.

Surveying over 1,000 UK women, the research found that 86% of respondents have tried multiple diet and weight loss programmes to lose weight with over half having previously committed to one or two different methods and a fifth admitting to trialling three to five different weight-loss methods. However, despite ambitions, many face barriers to their weight loss journeys.

While interested in trying GLP-1 medications, women have experienced blockers when trying to attain access to these medications including:

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

GLP-1 Weight Loss New Year's Resolutions Diet Fitness

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Viral Sleep Hack Claims To Work for EveryoneViral Sleep Hack Claims To Work for EveryoneA meditation teacher shares her unusual sleep tip that is gaining popularity on TikTok.
Read more »

Revolutionizing MASLD treatment with GLP-1 receptor agonistsRevolutionizing MASLD treatment with GLP-1 receptor agonistsResearchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic dysfunction-associated steatotic liver disease.
Read more »

Anti-obesity medications could help treat alcohol use disordersAnti-obesity medications could help treat alcohol use disordersLosing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the participants in a new study appearing in the current issue of JAMA Network Open.
Read more »

New compound HPH-15 offers promising alternative to diabetes medicationsNew compound HPH-15 offers promising alternative to diabetes medicationsKumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.
Read more »

Women skip post-stroke medications more often than men, study revealsWomen skip post-stroke medications more often than men, study revealsWomen, especially Mexican Americans, are more likely than men to skip critical post-stroke medications, highlighting the need for targeted interventions to improve adherence and reduce stroke recurrence.
Read more »

Financial hardship still prevents many asthma patients from taking medicationsFinancial hardship still prevents many asthma patients from taking medicationsDespite a fall in the number of people with asthma over the past decade who say that cost has stopped them taking their meds as prescribed, financial hardship still remains a deterrent for 1 in 6 with the condition, suggests research published online in the respiratory medicine journal Thorax.
Read more »



Render Time: 2025-02-15 13:31:44